GET THE APP

Editorial Note on Parkinson’s Disease | 78601

生物系统:开放获取

国际标准期刊号 - 2329-6577

抽象的

Editorial Note on Parkinson?s Disease

Alekhya Thirunahari

To control the motor and non-motor symptoms of Parkinson's disease, pharmacologic treatments (levodopa therapy [LVT]; dopamine agonists; MAO-B inhibitors; and COMPT-inhibitors) remain the frontline treatment choices (PD). Treatment with dopaminergic agents, especially agonist therapies (ATs), can, however, cause pernicious behavioural syndromes in some patients, which are classified as Impulse Control Disorders (ICDs) in the DSM-IV.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证